Kristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.
The Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.
Research by the DNA Damage & Disease research group has for the first time observed molecular fibres that may hold together sections of broken DNA in mitosis.
Researchers in Oxford have found that an individual\u2019s immune system \u2013 and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.
The Department of Oncology is pleased to announce that Professor Amato J Giaccia has been appointed as the new Director of the MRC Oxford Institute for Radiation Oncology (OIRO).
Researchers in the Department of Oncology have secured funding to characterise an insulin-like growth factor (IGF) signature for early detection and risk reduction of cancer.
Scientists from the Department of Oncology have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.
Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest \u00a310million in the National Consortium of Intelligent Medical Imaging (NCIMI), to be led from Oxford University as part of the Industrial Strategy Challenge Fund.
Congratulations to Dr Xiao Wan from Professor Eric O\u2019Neill\u2019s group for her success in obtaining an NC3Rs Training Fellowship for \u2018Developing human organotypic perfused bioreactors for physiologically reproducible therapeutic compound screening of a tumour microenvironment\u2019.
Congratulations to Dr Bart Cornelissen of the CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology who has secured a \u00a3200k grant from UK medical research charity, Pancreatic Cancer Research Fund (PCRF).
Dr James Larkin, a postdoctoral researcher from Nicola Sibson\u2019s lab in the CRUK/MRC Oxford Institute for Radiation Biology, has won a silver medal in 2018 STEM for Britain, a Parliamentary poster competition that gives researchers the chance to present their work to policymakers and politicians and discuss their work with local MPs.
Many congratulations to Robert Watson, a NIHR Academic Clinical Fellow in the laboratory of Benjamin Fairfax in the Department of Oncology. Robert was successful in his application for a CRUK pre-doctoral research bursary.
Congratulations to Associate Professor Francesca Buffa who has been awarded a five-year \u20ac2M grant by the European Research Council (ERC) to develop computer simulations of cancer cell behaviour, to help us personalise cancer treatment and prevent drug resistance.
![](\"https://www.oncology.ox.ac.uk/news/a-tempting-new-target-for-cancer-therapy/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n